Mirae Asset Global ETFs Holdings’s Janux Therapeutics JANX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$401K	Buy	26,137 +773	+3%	+$11.2K	﹤0.01%	2110
2026 Q1	$348K	Sell	25,364 -4,784	-16%	-$65.6K	﹤0.01%	2072
2025 Q4	$416K	Buy	30,148 +7,784	+35%	+$183K	﹤0.01%	1975
2025 Q3	$544K	Sell	22,364 -1,502	-6%	-$36.6K	﹤0.01%	1835
2025 Q2	$551K	Buy	23,866 +2,463	+12%	+$64.9K	﹤0.01%	1775
2025 Q1	$583K	Buy	21,403 +3,393	+19%	+$128K	﹤0.01%	1784
2024 Q4	$962K	Buy	18,010 +23	+0.1%	+$1.22K	﹤0.01%	1565
2024 Q3	$819K	Buy	17,987 +6,944	+63%	+$302K	﹤0.01%	1653
2024 Q2	$458K	Buy	+11,043	New	+$518K	﹤0.01%	1864

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's JANX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Janux Therapeutics (JANX) stake by 3% in Q2 2026, buying an estimated $11.2K and bringing the position to 26,137 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

Mirae Asset Global ETFs Holdings first reported a position in JANX in Q2 2024 and has held it in 9 quarters since. The position peaked at $962K in Q4 2024. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 26,137 shares of Janux Therapeutics worth $401K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 773 Janux Therapeutics shares in Q2 2026, an estimated $11.2K.
Janux Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2110 holding.
Mirae Asset Global ETFs Holdings first reported a position in Janux Therapeutics in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Janux Therapeutics position peaked at $962K in Q4 2024.
198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.